Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Adding Flubendazole to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma

NCT07847476 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07847476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Adding Flubendazole to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 1, 2028
Enrollment
122 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioma patients